The effects of ipragliflozin on the liver-to-spleen attenuation ratio as assessed by computed tomography and on alanine transaminase levels in Japanese patients with type 2 diabetes mellitus

We assessed the effects of a 12-week ipragliflozin treatment on the liver-to-spleen attenuation ratio (L/S ratio) using computed tomography and on alanine transaminase (ALT) levels in Japanese patients with type 2 diabetes mellitus (T2DM). Sixty-two patients with T2DM [age, 56 ± 8 years; hemoglobin...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Diabetol Int
Auteurs principaux: Bando, Yukihiro, Ogawa, Ayumi, Ishikura, Kazuhide, Kanehara, Hideo, Hisada, Azusa, Notumata, Kazuo, Okafuji, Kazuhiro, Toya, Daisyu
Format: Artigo
Langue:Inglês
Publié: Springer Japan 2017
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6224952/
https://ncbi.nlm.nih.gov/pubmed/30603325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13340-016-0302-y
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires